Antibe Therapeutics Inc.
ATBPF · OTC
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$4,213 | -$5,008 | -$5,786 | -$3,548 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $442 | -$79 | $416 | $451 |
| Change in WC | -$2 | -$1,345 | $786 | -$537 |
| Other Non-Cash | -$72 | $61 | $349 | $250 |
| Operating Cash Flow | -$3,845 | -$6,432 | -$4,584 | -$3,384 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $2 |
| Net Acquisitions | $0 | $0 | $0 | -$240 |
| Inv. Purchases | $0 | -$3,313 | -$10,109 | -$10,311 |
| Inv. Sales/Matur. | $10,166 | $5,095 | $16,731 | $10,000 |
| Other Inv. Act. | $875 | $2 | $7 | -$1 |
| Investing Cash Flow | $11,041 | $1,782 | $6,622 | -$549 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $159 |
| Financing Cash Flow | $0 | $0 | $0 | $159 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $7,196 | -$4,650 | $2,038 | -$3,774 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $4,143 | $8,793 | $6,755 | $10,529 |
| End Cash | $11,339 | $4,143 | $8,793 | $6,755 |
| Free Cash Flow | -$3,845 | -$6,432 | -$4,584 | -$3,382 |